Work

Aortic Stenosis and Heart Failure – Invasive Treatment and Prognosis

Year: 2021
Type: dissertation
Study design: Observational Study
Abstract: ABSTRACT Background: Aortic stenosis (AS) is one the most common heart valve diseases. Symptomatic AS leads to death within a few years if left untreated. For decades, open heart surgery with surgical aortic valve replacement (SAVR) was the only definitive treatment option. Since the first transcatheter aortic valve replacement (TAVR) procedure in 2002, the annual overall procedure numbers have increased over the last decade. Methods: The nationwide FinnValve registry was created to investigate the outcomes of TAVR and SAVR treatments in Finland from 2008 to 2017, herein with special interest in patients with heart failure. Results: The FinnValve registry includes data from 6463 patients who underwent primary TAVR (2130 patients) or SAVR with bioprosthesis (4333 patients) for severe AS. Annual SAVR and TAVR numbers were 367 and 21 in 2008, 565 and 181 in 2013 and 335 and 622 in 2017 (p<0.0001). Since 2008, two-year survival improved from 71.4% to 83.9% for TAVR (p<0.001), and from 87.2% to 91.6% for SAVR (p=0.006). The prevalence of recent acute heart failure and left ventricular systolic dysfunction were 11.4% and 20.8% in the SAVR cohort and 11.3% and 27.7% in the TAVR cohort, respectively. Both acute heart failure and systolic dysfunction were associated with increased morbidity and mortality after TAVR and SAVR when compared to no heart failure. After acute heart failure, 3-year survival in the TAVR cohort were 66.6% and in the SAVR cohort 68.6%, respectively (p=0.166). In patients with left ventricular dysfunction 4-year survival after TAVR was 65.9% and 69.6% after SAVR (RMST ratio, 1.002, 95%CI 0.929–1.080, p=0.964). Conclusions: TAVR has led to a more widespread use of invasive treatment for severe AS. Both acute heart failure and left ventricular dysfunction are associated with increased morbidity and mortality. TAVR is a valid alternative to SAVR in these patients. Intermediate survival is similar in heart failure patients KEYWORDS: Aortic stenosis, heart failure, surgical aortic valve replacement, SAVR, transcatheter aortic valve replacement, TAVR.
Institution: University of Turku
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W6989268880
Cites: 198
Cited by:
Related to: 9